The first cell rejuvenation therapy is set to enter clinics, testing if aging cells can be reset to a younger, healthier ...
Learn about Carbios' story, as the French biotech focused on recycling polyethylene terephthalate (PET), faces pressure after ...
Meet 5 hot biotechs in Arizona, from Phoenix to Tucson, that have raised significant funding over the past decade.
Rare Disease Day is held on the last day of February to raise awareness for rare diseases and address drug development ...
February 2026 saw a major biopharma acquisition, four key buyouts, and licensing deals in antibodies, small molecules, and ...
Delve into the field of pulmonary hypertension as GSK places a $950M bet on 35Pharma's candidate HS235 following the footsteps of Winrevair.
The companies Vaxcyte, Generate Biomedicines, and Immunic bagged the biggest biotech funding rounds overall in February 2026.
The longevity biotech industry revolves around the goal of increasing the period of life that a person spends in good health. There has been a rapidly expanding effort in recent years to develop drugs ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results